Pharmaceutical company Galderma has launched hyaluronic acid filler Restylane Eyelight to the UK.
According to the company, the Restylane Eyelight aims to reduce undereye shadows caused by a lack of volume and volume loss in the area. The product contains hyaluronic acid which is part of Galderma’s NASHA gel technology, combined with lidocaine, explains the company.
A clinical study by Galderma demonstrated that six and half months after the first treatment, 88.6% of people reported looking less tired and 91.4% of people still felt attractive due to the improvement in their dark circles. Also, 94.3% of people who tried Restylane Eyelight would recommend it to a friend and repeat treatment.
